Healthcare Market Research Reports

US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

25 years after the fall of the Soviet Union, Russia remains burdened with economic, social, and political crises. The recent ruble-oil crisis further weakened the economy. By examining the key Mega Trends in Russia, along with other factors that will impact and shape the country’s economy, this presentation discusses how the economic, political, ...